Increase FontDecrease Font

In Growth Investing, It's What's New that Counts


By Paul Goodwin, Editor of Cabot China & Emerging Markets Report
From Cabot Wealth Advisory 2/27/09 Sign up for free Cabot Wealth Advisory e-newsletter

For many years, the analysts at Cabot have had a running stock-picking contest that includes Paper Portfolios, a presentation from a different person each week and a prize of absolutely nothing at all. Each new member of the Wednesday Group receives a grant of $100,000 in hypothetical capital and invests it in any stocks that aren't in the Cabot Market Letter's Model Portfolio and that trade over a major exchange.

The amount of cash in the collective portfolios was used to help calculate our sentiment indicator, and it did a good job of serving as an overbought/oversold signal when it hit either high or low extremes.

I can remember the first big winning stock I ever dug out. It was Charles & Colvard (CTHR), a North Carolina manufacturer and merchandiser of moissanite, a rare, naturally occurring form of silicon carbide. Charles & Colvard figured out how to grow huge crystals of moissanite—which has a higher index of refraction than diamonds and is harder than rubies and emeralds—and began manufacturing fine jewelry featuring the stone.

Things went really well for a while and I "bought" my first CTHR shares at around 10 in March 2005 and rode it up to as high as 26 as volume spiked in December of that year. I followed the rules, adding to my stake as the stock moved higher, then taking some profits when it formed a climax top. The stock actually put me in the lead in our Paper Portfolio contest for a few weeks, even though the people I was competing against had been using the Cabot system for many years.

Ultimately, however, (long after I liquidated my last position, fortunately) the stock fell back to a narrow range just about where I first bought it, then started a determined dive toward penny stock territory as earnings deteriorated. The stock was trading below 20 cents a share for a while during last year's November market trough. An announcement a few weeks ago that the company had fired its CEO, Senior VP of Sales and VP of Operations gives a little insight into the turmoil into which this once-hot company had fallen.

CTHR is now trading at 40 cents a share, indicating that the stock market's bottom feeders have found enough evidence of potential to take a few small bites. But with volume averaging just 28,000 shares a day, the stock is an object lesson, not a real investment. 

In fact, I'm only bringing it up to show how being involved with a stock Charles & Colvard I mean really getting to know it and the company's marketing plans and the whole nine yards Charles & Colvard can make you want to keep up with it like an old high-school girlfriend. I check up on the stock every once in a while, just like I stay in touch with old friends. But I'm never, repeat never, tempted to buy a little for old time's sake.

In growth investing, it's what's new that counts. 

Information on Cabot China & Emerging Markets Report
Information on Cabot Market Letter

Cabot Technical Analysis
General Investing Advice
Sign up for free Cabot Wealth Advisory e-newsletter
More on Growth Investing
Cabot Home

Cabot's Blog


Which Cabot Letter is Right for You?

Take the Cabot quiz


Traditional growth investors subscribe to our flagship Cabot Market Letter or Cabot Green Investor.

Aggressive investors are comfortable with the high-momentum stocks in Cabot Top Ten Report or the fast-growing foreign stocks in Cabot China & Emerging Markets Report.

Conservative investors follow the Cabot Benjamin Graham Value Letter to invest in high-quality undervalued stocks.

Long term investors find undiscovered emerging companies in Cabot Small-Cap Confidential.

If you're not sure, Cabot Stock of the Month Report will help you build a diversified portfolio of growth, green, momentum, international and value stocks.